Intellia Therapeutics (NTLA) – Upgrades
-
Intellia Therapeutics (NTLA) risk-reward 'now skewed to the upside' - BMO Capital Markets
-
BMO Capital Upgrades Intellia Therapeutics (NTLA) to Outperform, 'Risk/Reward Is Now Skewed to the Upside'
-
-
-
-
-
-
-
-
-
-
Back to NTLA Stock Lookup